Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
İbrahim Aydın
Observed name:
I. Aydin
Institution:
Ministry of Health
Observed institution:
Ministry of Health
ORCID:
0000-0001-5850-4808
Observed ORCID:
0000-0001-5850-4808
OpenAlex ID:
A5025454926
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
·
9
PDF
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2026
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
PDF
Prognostıc Factors In Testıcular Cancer
2024
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Turkish Journal of Clinics and Laboratory
PDF
Effect of vitamin D on prognosis in patients with gastric cancer
2024
·
Yasin Sezgin
, İbrahim Aydın
, et al.
·
Journal of Current Hematology & Oncology Research
962 Minimal invasive PCNL (MPCNL) – update on efficacy and safety after 745 consecutive patients
2013
·
V. Zimmermanns
, I. Aydin
, et al.
·
European Urology Supplements
Show more works
View as search
Works count:
5
Citation count:
9
H-index:
1
I10-index:
Year
Topic
Type